Isolation of cosmids corresponding to the chromosome breakpoints of a de novo autosomal translocation, t(6;19)(p21;q13.1), in a patient with multicystic renal dysplasia.
Hydronephrosis caused by pelvi-ureteric junction obstruction (PUJO) is a frequent urological malformation assumed to result from a deficient development of the ureteric bud. The exact etiology of pelvi-ureteric junction stenosis is unknown, but there is convincing evidence for a genetic cause, with linkage analysis predicting a hereditary hydronephrosis locus on chromosome 6p. We encountered a patient with a de novo autosomal t(6;19)(p21;q13.1) and attendant bilateral multicystic renal dysplasia (MRD), bilateral PUJO resulting in massive hydronephrosis, and an associated von Mayer-Rokitansky-Kuster disorder. On the basis of the presumption that in this patient the putative hydronephrosis gene might be disrupted by the translocation, we sought to isolate DNA from the breakpoint regions as the initial step in a strategy to identify genes affected by the t(6; 19). Using sequential rounds of fluorescence in situ hybridization (FISH) with cosmids selected from a detailed integrated map of the long arm of chromosome 19, we have identified a cosmid clone that spans the breakpoint. The position of the breakpoint was further localized by Southern blot analysis. Using a vectorette PCR approach, rearranged DNA fragments were isolated and, by comparative nucleotide sequence analysis, these were shown to contain ectopic sequences. A cosmid clone containing these ectopic sequences was isolated and shown by CASH (chromosome assignment using somatic cell hybrids) and FISH (fluorescence in situ hybridization) analysis to map to the short arm of chromosome 6 and to span the breakpoint found in the MRD patient. The isolated cosmid clones are useful reagents for analysis of other MRD patients and for the search for genes at or flanking the breakpoints.
Groenen
P M
PM
Laboratory for Molecular Oncology, Center for Human Genetics, University of Leuven(Belgium).
Garcia
E
E
Thoelen
R
R
Aly
M
M
Schoenmakers
E F
EF
Devriendt
K
K
Fryns
J P
JP
Van de Ven
W J
WJ
D000328:Adult; D002869:Chromosome Aberrations / Q000196:embryology / Q000235:genetics*; D025063:Chromosome Disorders; D002888:Chromosomes, Human, Pair 19 / Q000648:ultrastructure*; D002896:Chromosomes, Human, Pair 6 / Q000235:genetics / Q000648:ultrastructure*; D003360:Cosmids / Q000235:genetics*; D004247:DNA / Q000235:genetics; D005260:Female; D005315:Fetal Diseases / Q000235:genetics*; D005347:Fibroblasts / Q000473:pathology; D006801:Humans; D006869:Hydronephrosis / Q000196:embryology / Q000235:genetics*; D017404:In Situ Hybridization, Fluorescence; D007682:Kidney Pelvis / Q000002:abnormalities* / Q000196:embryology; D008168:Lung / Q000473:pathology; D016104:Oligohydramnios / Q000209:etiology; D007690:Polycystic Kidney Diseases / Q000196:embryology / Q000235:genetics*; D016133:Polymerase Chain Reaction; D011247:Pregnancy; D014178:Translocation, Genetic / Q000235:genetics*; D014513:Ureter / Q000002:abnormalities* / Q000196:embryology; D014517:Ureteral Obstruction / Q000196:embryology / Q000209:etiology
D004247:DNA